The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 3 March 2009, www.theannals.com, DOI 10.1345/aph.1L496.
The Annals of Pharmacotherapy: Vol. 43, No. 3, pp. 413-422. DOI 10.1345/aph.1L496
© 2009 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansen, R. A
Right arrow Articles by Murray, M. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, R. A
Right arrow Articles by Murray, M. D

ADHERENCE

Comparison of Methods to Assess Medication Adherence and Classify Nonadherence

Richard A Hansen, PhD

Associate Professor, Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Mimi M Kim, PhD

Research Associate/Investigator, Shaw University, Institute for Health, Social, and Community Research, Raleigh, NC

Liping Song, MAS PhD

at time of writing, Research Associate, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; now, Statistician, Department of Nonclinical Statistics, Merck & Co., Inc., West Point, PA

Wanzhu Tu, PhD

Associate Professor, Division of Biostatistics, School of Medicine, Indiana University, Indianapolis, IN; Regenstrief Institute, Inc., Indianapolis

Jingwei Wu, MS

Biostatistician, Division of Biostatistics, School of Medicine, Indiana University

Michael D Murray, PharmD MPH

Mescal S Ferguson Distinguished Professor, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Regenstrief Institute, Inc.

Reprints: Dr. Hansen, Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Campus Box 7360, 2205 Kerr Hall, Chapel Hill, NC 27599, fax 919/966-8486, rahansen{at}unc.edu

BACKGROUND: Medication adherence is suboptimal, and clinicians and researchers struggle with identifying nonadherent patients. Various measures of medication adherence exist, but there is controversy regarding which measures provide acceptable data and how nonadherence should be defined.

OBJECTIVE: To assess agreement among patient self-report, pharmacy refill, and electronic adherence measures and compare the sensitivity and specificity of different cut-points for defining nonadherence.

METHODS: Data were analyzed from 2 similarly designed randomized controlled trials that assessed a pharmacist's intervention to improve medication adherence among patients with hypertension or heart failure. For each participant, adherence was measured by patient self-report, prescription refill records, and electronic lids on medication containers. Agreement among measures was assessed using Spearman's correlation coefficient rho. Correlation coefficients were compared by patient characteristics using Fisher's Z transformation. The sensitivity and specificity of different cut-points for defining nonadherence were calculated.

RESULTS: Median adherence was 84% for self-report, 86% for electronic, and 91% for prescription refill adherence measurement. Refill and electronic adherence demonstrated the best agreement among measures (rho = 0.48). Age, depression, and other comorbid conditions influenced agreement among measures. Measures were generally in agreement, regardless of how nonadherence was defined. A cut-point of 80% illustrated a fair balance between sensitivity and specificity for all measures.

CONCLUSIONS: All measures provided similar estimates of overall adherence, although refill and electronic measures were in highest agreement. In selection of a measure, practitioners should consider population and disease characteristics, since measurement agreement could be influenced by these and other factors. The commonly used, clinically based cut-point of 80% had a reasonable balance between sensitivity and specificity in studies of adherence in patients with heart failure or hypertension.

Key Words: adherence, electronic lids, refill records, self-report

Published Online, March 3, 2009. www.theannals.com, DOI 10.1345/aph.1L496


This article has been cited by other articles:


Home page
Psychosom. Med.Home page
H. K. Kim, J. H. Park, J. H. Park, and J. H. Kim
Differences in Adherence to Antihypertensive Medication Regimens According to Psychiatric Diagnosis: Results of a Korean Population-Based Study
Psychosom Med, January 1, 2010; 72(1): 80 - 87.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
T. H James, M. L Helms, and R. Braund
Analysis of Medications Returned to Community Pharmacies
Ann. Pharmacother., October 1, 2009; 43(10): 1631 - 1635.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2009 by Harvey Whitney Books Company.